Hansoo Kim

A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia

Megan Bohensky, Kumar Pasupathi, Alexandra Gorelik et al. · Value in Health · 2016 · 31 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +12

Health Technology Assessment in Australia: The Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee

Hansoo Kim, Joshua Byrnes, Stephen Goodall · Value in Health Regional Issues · 2021 · 27 citations · Full text

Public Affairs, Health Policy, Pharmacoeconomics +16

A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma

Hansoo Kim, S. Comey, Karl Georg Häusler et al. · Journal of Pharmaceutical Policy and Practice · 2018 · 19 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +17

Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis

Hansoo Kim, G. T. Cook, Stephen Goodall et al. · PharmacoEconomics - Open · 2021 · 13 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

A randomized, double-blind, controlled trial of the effect of adding follicular fluid meiosis activating sterol in an ethanol formulation to donated human cumulus-enclosed oocytes before fertilization

Anne Gitte Loft, Christina Bergh, Søren Ziebe et al. · Fertility and Sterility · 2004 · 12 citations

Veterinary Medicine, Gynecology, Obstetrics +13